Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT01905228
Previous Study | Return to List | Next Study

A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm or Refractory Lymphomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Incuron
Sponsor:
Information provided by (Responsible Party):
Incuron
ClinicalTrials.gov Identifier:
NCT01905228
First received: July 9, 2013
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)